These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6998684)

  • 1. Comparison of the acute and chronic hemodynamic effects of captopril and guanethidine in spontaneously hypertensive rats.
    Ferrone RA; Heran CL; Antonaccio MJ
    Clin Exp Hypertens (1978); 1980 Feb; 2(2):247-72. PubMed ID: 6998684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of captopril and enalapril on regional vascular resistance and reactivity in spontaneously hypertensive rats.
    Richer C; Doussau MP; Giudicelli JF
    Hypertension; 1983; 5(3):312-20. PubMed ID: 6188693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of captopril on the development of tolerance to guanethidine.
    Rankin GO; Haas GJ
    Fed Proc; 1984 Apr; 43(5):1342-5. PubMed ID: 6323227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal and uteroplacental hemodynamic effects of chronic captopril in the hypertensive, term-pregnant rat.
    Mabie WC; Ahokas RA; Sibai BM
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 1):1861-7. PubMed ID: 2256496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of angiotensin-converting enzyme inhibition by captopril on cardiac output, coronary blood flow, and systemic arterial blood pressure in the intact and in the bilaterally nephrectomized rabbit.
    Ohmae M; Rabkin SW; Fung HY
    J Cardiovasc Pharmacol; 1981; 3(5):1060-7. PubMed ID: 6168851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-hypertensive action of Captopril. Hemodynamic study (author's transl)].
    Levenson J; Simon A; Temmar M; Safar M
    Nouv Presse Med; 1980 Feb; 9(9):617-9. PubMed ID: 6987622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of captopril on renal hemodynamics in hypertensive patients.
    Duchin KL; Willard DA
    J Clin Pharmacol; 1984; 24(8-9):351-9. PubMed ID: 6384279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular responses of conscious DOCA-salt hypertensive rats to acute intracerebroventricular and intravenous administration of captopril.
    Pochiero M; Nicoletta P; Losi E; Bianchi A; Caputi AP
    Pharmacol Res Commun; 1983 Feb; 15(2):173-82. PubMed ID: 6342005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of reserpine, guanethidine and methyldopa on cardiac output and its distribution.
    Kisin I; Yuzhakov S
    Eur J Pharmacol; 1976 Feb; 35(2):253-60. PubMed ID: 1248504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal hemodynamic effects of nonhypotensive doses of angiotensin-converting enzyme inhibitors in hypertension and heart failure rats.
    Nelissen-Vrancken HJ; Struijker-Boudier HA; Smits JF
    J Cardiovasc Pharmacol; 1992 Feb; 19(2):163-8. PubMed ID: 1376783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic response to captopril at rest and during exercise in hypertensive patients.
    Fagard R; Lijnen P; Amery A
    Am J Cardiol; 1982 Apr; 49(6):1569-71. PubMed ID: 7041600
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemodynamic effects of captopril in one-kidney, one clip hypertensive rabbits.
    Kogure M; Ichikawa S; Sakamaki T; Matsuo H; Tajima Y; Fujita H; Murata K
    Clin Exp Hypertens A; 1984; 6(5):1035-54. PubMed ID: 6375906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of captopril infusion on systemic and renal haemodynamics in conscious hypertensive rats with chronic, progressive aortic ligation.
    Gonzalez-Perez LM; Martin-Paredero V; Casado S; Lopez-Novoa JM
    Eur J Clin Invest; 1985 Dec; 15(6):355-9. PubMed ID: 3938404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of reserpine, guanethidine and methyldopa on general and regional hemodynamics].
    Iuzhakov SD; Kotliarov EV
    Farmakol Toksikol; 1973; 26(4):429-32. PubMed ID: 4789888
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemodynamic and regional blood flow response to captopril in congestive heart failure.
    Levine TB; Olivari MT; Cohn JN
    Am J Med; 1984 May; 76(5B):38-42. PubMed ID: 6375361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of converting enzyme inhibitor on hepatic blood flow in man.
    Crossley IR; Bihari D; Gimson AE; Westaby D; Richardson PJ; Williams R
    Am J Med; 1984 May; 76(5B):62-5. PubMed ID: 6328986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic responses to combined therapy with captopril and hydralazine in patients with severe heart failure.
    Massie BM; Packer M; Hanlon JT; Combs DT
    J Am Coll Cardiol; 1983 Aug; 2(2):338-44. PubMed ID: 6345633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and chronic systemic and pulmonary hemodynamic effects of angiotensin converting enzyme inhibition with captopril in hypertensive patients.
    Fagard R; Amery A; Reybrouck T; Lijnen P; Billiet L
    Am J Cardiol; 1980 Aug; 46(2):295-300. PubMed ID: 6250392
    [No Abstract]   [Full Text] [Related]  

  • 19. Angiotensin II/prostaglandin I2 interactions in spontaneously hypertensive rats.
    Jackson EK; Herzer WA
    Hypertension; 1993 Nov; 22(5):688-98. PubMed ID: 8225529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Captopril-induced changes in large arteries in essential hypertension.
    Simon AC; Levenson JA; Bouthier JL; Safar ME
    Am J Med; 1984 May; 76(5B):71-5. PubMed ID: 6328988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.